Prof. MD. Duygu Derin
Medical Oncology
Areas Of Interests
World-Class Medical Oncology: Advanced Treatments and Patient-Centric Care for Superior Outcomes
Prof. MD. Duygu Derin is a distinguished medical oncologist at Liv Hospital, celebrated for her patient-focused approach and dedication to delivering world-class cancer care. With over two decades of experience in oncology, Dr. Derin combines clinical expertise, cutting-edge technology, and compassionate care to provide personalized treatment plans for her patients. Her medical journey began with a degree from Istanbul University Istanbul Medical Faculty, followed by specialization in Internal Diseases and Medical Oncology. She further refined her expertise at leading institutions, including Istanbul University Oncology Institute and Istanbul American Hospital, where she managed complex cancer cases with precision and care.
Dr. Derin’s clinical practice is built on advanced technology and evidence-based methodologies, ensuring that every treatment plan meets the highest global standards. Her expertise spans a wide range of cancers, including breast, lung, gastrointestinal, and hematologic malignancies. At Liv Hospital, she employs innovative therapies and minimally invasive techniques that prioritize patient comfort and faster recovery. Dr. Derin’s commitment to achieving optimal clinical outcomes is matched by her compassionate approach, ensuring that each patient feels supported throughout their treatment journey. Her international exposure and extensive experience in leading oncology centers have equipped her with a global perspective, enabling her to integrate the latest advancements in cancer care into her practice.
Prof. MD. Duygu Derin is not only a clinical expert but also a respected academic authority in the field of medical oncology. As an Associate Professor, she has made significant contributions to oncology research, with numerous publications in prestigious international journals. Her research focuses on advancing cancer diagnostics and treatments, particularly in the areas of targeted therapies and personalized medicine. This commitment to scientific innovation ensures that her patients benefit from the most current and effective treatment options.
In addition to her research, Dr. Derin is a dedicated educator, mentoring the next generation of oncologists and sharing her expertise through academic roles at leading institutions. Her leadership in both clinical and academic settings has solidified her reputation as a trusted name in oncology, both in Turkey and internationally. Patients at Liv Hospital can rest assured that their care is guided by a medical oncologist whose practice is built on the principles of scientific excellence, patient-centered care, and a relentless pursuit of better outcomes.
Dr. Derin’s unwavering dedication to integrating advanced treatments, cutting-edge technology, and compassionate care has made her a beacon of hope for patients facing cancer. Her holistic approach ensures that every aspect of her patients’ well-being is addressed, making her a trusted partner in their journey toward recovery.
- A phase 3 study of the new Epatilon BMS247550+capesitabine in patients with advanced breast cancer previously treated with an anthracycline or taxane. Prot no: CA163048. Coordination center: Hacettepe Medical Faculty. Responsible coordinator: Prof. Dr. Esmen Baltaci. Co-investigator: Dr. Duygu Derin
- A phase 3 randomized placebo-controlled double-blind study comparing oral CCI-779 in combination with letrozole versus letrozole alone in first-line hormone therapy in postmenopausal women with locally advanced or metastatic breast carcinoma. Prot no: 3066A1-303WW. Coordination center: Istanbul University Oncology Institute. Responsible coordinator: Prof.Dr. Pınar Saip. Co-investigator: Dr. Duygu Derin
- Soydinc, H.O., Duranyildiz, D., Guney, N., Derin, D., Yasasever, V. ''Utility of serum and urine uPAR levels for diagnosis of breast cancer. Asian Pac J Cancer Prev. 2012;13(6):2887-9.
- Vural, B., Yakar, F., Derin, D., Saip, P., Yakar, A., Demirkan, A., Karabulut, A., Ugurel, E., Cine, N., Kilicaslan, Z., Tüzün, E., Ozbek, U. ''Küçük hücreli akciğer kanserli hastalarda glutatyon S-transferaz P1 polimorfizmlerinin (Ile105Val ve Ala114Val) değerlendirilmesi. Genet Test Mol Biomarkers. 2012 Jul;16(7):701-6. doi: 10.1089/gtmb.2011.0315. Epub 2012 Feb 17.
- Saip, R., Sen, F., Vural, B., Ugurel, E., Demirkan, A., Derin, D., Eralp, Y., Camlica, H., Ustuner, Z., Ozbek, U. ''Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. J BUON. 2011 Apr-Jun;16(2):241-6.
- Ozluk, Y., Kilicaslan, I., Kazancioglu, R., Demirkesen, C., Derin, D., Mandel, N.M. ''Intraglomerular crescentic metastases of malignant melanoma. Hum Pathol. 2011 Dec;42(12):2025-8. doi: 10.1016/j.humpath.2010.05.032. Epub 2011 Jun 12.
- Beyazıt, H., Aydın, O., Demirkesen, C., Derin, D., Süt, P., Emre, A., Mandel,N. ''Gastrik adenokarsinom seyri sırasında pankreas tutulumunun ilk belirtisi olarak pankreatik pannikülit'' Med Oncol. 2011 Mar;28(1):137-9. doi: 10.1007/s12032-010-9420-8. Epub 2010 Jan 30.
- Bitisik, O., Saip, P., Saglam, S., Derin, D., Dalay, N. ''Mammaglobin and maspin transcripts in blood may reflect disease progression and treatment effect in breast cancer. Genet Mol Res. 2010;9(1):97-106.
- Basaran, G., Okkan, S., Çaglar, H., Benekli, M., Gümüş, M., Haydaroğlu , A., Eralp, Y., Abalı, H., Yıldız, F., Bese, N., Gursel, B., Guney, N., Derin, D. ''Immunohistochemically Defined T1N0 Breast Cancer SungroupsHave Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study. '' Cancer Research 02/2010 69(24 supplement) 3167-3167 DOI: 10.11580008-5472 SABCS-09-3167
- Can, G., Topuz, E., Derin, D., Durna, Z., Aydıner, A. ''The effect of kefir on quality of life in colorectal cancer patients. Oncol Nurs Forum. 2009 Nov;36(6):E335-42. doi: 10.1188/09.ONF.E335-E342.
- Guney, N., Soydinc, H.O., Basaran, M., Bavbek, S, Derin, D., Camlica, H., Yasasever, V., Topuz, E. ''Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):669-74.
- Guney, N., Sayilgan, T., Derin, D., Ozcan, D. ''Primary carcinoid tumor arising in mature cystic teratoma of the ovary: a case report''. Eur J Gynaecol Oncol. 2009;30(2):223-5.
- Medical Oncology Society
- Chamber of Medicine
- Galatasaraylılar Fan Society
- Turkish Cancer Research and Warfare Organization (XVIIth National Cancer Congress) Oncology Research Second Prize: Oguzsoydinç,H., Çamlıca, H., Duranyılmaz, D., Güney, N., Derin, D., Taş, F., Dalay, N., Yasasever, V. "The Utility of the Serum and Urine UPAR Levels in Breast Cancer''
